PNC Financial Services Group
PRTK

PNC Financial Services Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

PNC Financial Services Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-392
Closed -$2K – 4806
2022
Q1 		$2K Hold
392
– – ﹤0.01% 4255
2021
Q4 		$2K Hold
392
– – ﹤0.01% 4214
2021
Q3 		$2K Hold
392
– – ﹤0.01% 4159
2021
Q2 		$2K Buy
392
+174
+80% +$1.41K ﹤0.01% 4071
2021
Q1 		$2K Hold
218
– – ﹤0.01% 3986
2020
Q4 		$2K Hold
218
– – ﹤0.01% 3870
2020
Q3 		$0 Hold
218
– – ﹤0.01% 4093
2020
Q2 		$0 Sell
218
-9
-4% -$40 ﹤0.01% 4091
2020
Q1 		$0 Sell
227
-71
-24% -$262 ﹤0.01% 4099
2019
Q4 		$0 Buy
298
+70
+31% +$243 ﹤0.01% 4142
2019
Q3 		$1K Buy
228
+116
+104% +$464 ﹤0.01% 3950
2019
Q2 		$0 Sell
112
-27
-19% -$128 ﹤0.01% 4169
2019
Q1 		$0 Buy
139
+9
+7% +$58 ﹤0.01% 4158
2018
Q4 		$0 Buy
130
+18
+16% +$137 ﹤0.01% 4217
2018
Q3 		$2K Hold
112
– – ﹤0.01% 3981
2018
Q2 		$2K Sell
112
-880
-89% -$9.96K ﹤0.01% 4006
2018
Q1 		$12K Buy
992
+60
+6% +$893 ﹤0.01% 3651
2017
Q4 		$16K Buy
932
+52
+6% +$1.08K ﹤0.01% 3505
2017
Q3 		$22K Hold
880
– – ﹤0.01% 3353
2017
Q2 		$22K Buy
+880
New +$19.5K ﹤0.01% 3307

Other funds holding PRTK

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return

PNC Financial Services Group's PRTK Position: Q2 2022 in Review

PNC Financial Services Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2022, closing a stake of 392 shares — an estimated $2K sold.

PNC Financial Services Group first reported a position in PRTK in Q2 2017 and held it in 20 quarters. The position peaked at $22K in Q3 2017. 84 funds tracked by Wall St. Rank hold PRTK as of Q2 2022.

  • PNC Financial Services Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 392 Paratek Pharmaceuticals, Inc. shares in Q2 2022, an estimated $2K.
  • PNC Financial Services Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2017 and held it in 20 quarters.
  • PNC Financial Services Group's Paratek Pharmaceuticals, Inc. position peaked at $22K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2022.

Based on PNC Financial Services Group's 13F filing for Q2 2022, filed 12 Aug 2022.